$FOUR

Shift4 Payments, Inc.

0
1
1

No SEC Form 4 filings for $FOUR in the last 30 days.

See all $FOUR insider activity →
Low

B.Riley cuts Shift4 Payments stock price target on travel concerns

B.Riley reduced its price target on Shift4 Payments (NYSE:FOUR) to $94 from $96, citing concerns about global travel trends. The firm lowered its 2026 and 2027 EPS estimates to $5.16 and $6.23, respectively. Shift4 is expected to generate $500M in free cash flow this year, with a 16% free cash flow yield. Other analysts have also adjusted their price targets, with mixed outlooks on the company's growth prospects.

Shift4 Payments (FOUR): A Stock Priced for Trouble, a Business Still Compounding Underneath

Shift4 Payments (FOUR) lowered its full-year outlook due to Middle East travel disruption and foreign exchange pressure. Despite this, Q3 results beat guidance with 34% gross revenue growth and 51% growth in gross revenue less network fees. Analysts have mixed views, with some seeing the stock as undervalued and others cautioning about aggressive growth models. The company refinanced debt, extending maturities to 2031.

FOUR sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning FOUR (Shift4 Payments, Inc.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.

Recent FOUR coverage spans financial news, market movers and corporate actions.

What's driving FOUR

AlphAI scores every news story that mentions FOUR with an AI model for sentiment and relevance, and aggregates insider trades from Shift4 Payments, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $FOUR

Score

B.Riley cuts Shift4 Payments stock price target on travel concerns

B.Riley reduced its price target on Shift4 Payments (NYSE:FOUR) to $94 from $96, citing concerns about global travel trends. The firm lowered its 2026 and 2027 EPS estimates to $5.16 and $6.23, respectively. Shift4 is expected to generate $500M in free cash flow this year, with a 16% free cash flow yield. Other analysts have also adjusted their price targets, with mixed outlooks on the company's growth prospects.

Shift4 Payments (FOUR): A Stock Priced for Trouble, a Business Still Compounding Underneath

Shift4 Payments (FOUR) lowered its full-year outlook due to Middle East travel disruption and foreign exchange pressure. Despite this, Q3 results beat guidance with 34% gross revenue growth and 51% growth in gross revenue less network fees. Analysts have mixed views, with some seeing the stock as undervalued and others cautioning about aggressive growth models. The company refinanced debt, extending maturities to 2031.

$FOURMed

StoneX cuts Shift4 Payments stock price target on war impact

StoneX reduced its price target for Shift4 Payments (NYSE:FOUR) to $56 from $67, citing the impact of the Iran war on its business, particularly tax-free shopping transactions. The stock has fallen 55% over the past year and is currently trading at $39.28. Analysts have mixed views, with some lowering targets and others upgrading the stock.

Analysts Have Conflicting Sentiments on These Technology Companies: Shift4 Payments (FOUR), CrowdStrike Holdings (CRWD) and Salesforce (CRM)

Analysts provided mixed ratings for three tech companies. Truist's Matthew Coad maintained a Hold rating on Shift4 Payments (FOUR) with a $49 price target. CrowdStrike (CRWD) received a Buy rating from Cantor Fitzgerald's Jonathan Ruykhaver with a $250 target. Salesforce (CRM) was reiterated as Buy by Cantor Fitzgerald's Matthew VanVliet with a $250 target. Consensus ratings and targets vary for each company.

Shift4 (FOUR) Stock Is Up, What You Need To Know

Shift4 Payments (FOUR) stock rose 4.6% after Wells Fargo upgraded it to Overweight, citing international synergies and stronger free cash flow. The firm raised its price target to $59. Despite FX headwinds, shares cooled to $49.86, up 3.9%. Q2 revenue grew 34% to $1.3B, but guidance was cut due to Middle East disruptions and FX impacts.

$DKSMed

Stocks making the biggest moves midday: Dick's Sporting Goods, Marvell, AMD, Kura Oncology & more

Dick's Sporting Goods (DKS) fell 27% after reporting $5.59B in sales, missing estimates. Dynatrace (DT) rose 3% on a Morgan Stanley upgrade. Shift4 Payments (FOUR) gained 4% after a Wells Fargo upgrade. Moderna (MRNA) climbed 13% following a Wolfe Research upgrade. Marvell (MRVL) jumped 5% on higher price targets. AMD (AMD) rose 5% after a Raymond James upgrade. Kura Oncology (KURA) gained 10% after CEO bought shares. Navitas Semiconductor (NVTS) rose 5% on a $232.8M deal with Claros.

Related tickers